BISPECIFIC ANTIBODY AGAINST BCMA AND CD3 AND AN IMMUNOLOGICAL DRUG FOR COMBINED USE IN TREATING MULTIPLE MYELOMA

BISPECIFIC ANTIBODY AGAINST BCMA AND CD3 AND AN IMMUNOLOGICAL DRUG FOR COMBINED USE IN TREATING MULTIPLE MYELOMA

The invention relates to a bispecific antibody specifically binding to human B cell maturation antigen (BCMA) and to human CD3ɛ (CD3) together with an immunotherapeutic drug for combined use in treating multiple myeloma.. La invención hace referencia a un anticuerpo biespecifico que se une de forma...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: Jesús Fernando SAN MIGUEL IZQUIERDO, Klaus STREIN, Minh Diem VU, Bruno David Lourenço PAIVA
Format: Patent
Sprache:eng ; spa
Schlagworte:
CHEMISTRY
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
METALLURGY
ORGANIC CHEMISTRY
PEPTIDES
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
Online-Zugang:Volltext bestellen
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:The invention relates to a bispecific antibody specifically binding to human B cell maturation antigen (BCMA) and to human CD3ɛ (CD3) together with an immunotherapeutic drug for combined use in treating multiple myeloma.. La invención hace referencia a un anticuerpo biespecifico que se une de forma específica al antígeno de maduración de linfocitos B (BCMA) humano y al CD3e (CD3) humano, junto con un fármaco inmunoterapeutico para uso combinado en el tratamiento del mieloma múltiple.